Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Theratechnologies (NASDAQOTCBB:THERF)

CAPS Rating: No stars

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

How do you think NASDAQOTCBB:THERF will perform against the market?

Add Stock to CAPS Watchlist

All Players

7 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQOTCBB:THERF Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

StoppedOut (< 20)
Submitted May 28, 2018

Massive growth from sales of recently FDA approved drug Trogarzo.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQOTCBB:THERF VS S&P 500 (SPY)

NASDAQOTCBB:THERF Summary

Fools bullish on NASDAQOTCBB:THERF are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about THERF.

Recs

1
Member Avatar StoppedOut (< 20) Submitted: 5/27/2018 10:50:35 PM : Outperform Start Price: $10.92 NASDAQ OTC:THERF Score: -109.05

Massive growth from sales of recently FDA approved drug Trogarzo.

Recs

1
Member Avatar Fiscaldrone (76.29) Submitted: 6/14/2010 9:53:50 PM : Outperform Start Price: $5.06 NASDAQ OTC:THERF Score: -276.69

FDA approval of Tesamoralin passed. Hired management with track record to produce new product into the market place in late October 2010

Recs

1
Member Avatar cmendress (< 20) Submitted: 5/7/2009 10:02:36 AM : Outperform Start Price: $2.33 NASDAQ OTC:THERF Score: -263.26

This stock is trading near cash value. The main drug tesmorelin is proven to be effective at obesity reduction and positive health affects. It is in the III phase of testing and could receive priority processing from the FDA. The first FDA application is for aid patients and likely second application will be for the broader obesity market. The upside is massive. Current Valuation is $6.

Leaderboard

Find the members with the highest scoring picks in THERF.

Score Leader

TSIF

TSIF (99.98) Score: +144.34

I caught Theratechnologies on a short, but steep drop caused by safety concerns on its aids related drug. The drug did pass and THTCF is looking to list on the NASDAQ and go into production. 3/11

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
tyler1952 < 20 8/15/2018 Outperform 3Y $6.78 -44.10% +37.61% -81.71 0 Comment
StoppedOut < 20 5/29/2018 Outperform 5Y $10.92 -65.29% +43.75% -109.05 1 Comment
Munchenman77 60.80 12/3/2009 Outperform 5Y $3.56 +6.46% +248.35% -241.89 0 Comment
bigbonesmagoo 26.90 10/18/2010 Outperform 5Y $4.60 -17.62% +230.03% -247.65 0 Comment
cmendress < 20 5/7/2009 Outperform 3Y $2.33 +63.01% +326.28% -263.26 1 Comment
GBPackerfanz 63.83 9/2/2010 Outperform 5Y $4.70 -19.36% +256.82% -276.18 0 Comment
Fiscaldrone 76.29 6/14/2010 Outperform 5Y $5.06 -25.10% +251.59% -276.69 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for THERF.